retatrutide triple agonist gip glp-1 glucagon phase 3 2025 Eli Lilly's shows promising weight loss results in trial Retatrutide vs. Tirzepatide: The Next-Gen
Description
with a GLP-1
Purpose Chronic kidney disease (CKD) is one of the most common complications of type 2 diabetes (T2D), and CKD-related disability and mortality are increasing despite the recent advances in diabetes management
Serena Williams recently shared that she started taking the GLP-1 drug Zepbound after having her two children
Pfizer's obesity pill danuglipron has not progressed to Phase 3 trials and is not approved in the UK
Why does GLP-1 cause pancreatitis
Ozempic can be difficult to get and isn't appropriate for everyone
